Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Harvard Business School
Medtronic
Baxter
Johnson and Johnson

Last Updated: May 21, 2022

CLINICAL TRIALS PROFILE FOR DOBUTREX


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Dobutrex

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00219388 ↗ Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients. Completed Orion Corporation, Orion Pharma Phase 4 2002-11-01 The purpose of this study is to compare the effects of levosimendan with dobutamine on heart function in patients suffering of severe chronic heart failure.
NCT00763035 ↗ Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) Terminated Astellas Pharma US, Inc. Early Phase 1 2009-01-01 The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators will compare regadenoson with dobutamine so each participant will undergo two studies. A cardiac MR stress test with regadenoson and with dobutamine. The investigators participants will include patients with history of COPD and Asthma, so it will also help us determine feasibility of Regadenoson in these patient's subgroups.
NCT00763035 ↗ Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) Terminated Wake Forest Baptist Health Early Phase 1 2009-01-01 The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators will compare regadenoson with dobutamine so each participant will undergo two studies. A cardiac MR stress test with regadenoson and with dobutamine. The investigators participants will include patients with history of COPD and Asthma, so it will also help us determine feasibility of Regadenoson in these patient's subgroups.
NCT00763035 ↗ Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) Terminated Wake Forest University Health Sciences Early Phase 1 2009-01-01 The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators will compare regadenoson with dobutamine so each participant will undergo two studies. A cardiac MR stress test with regadenoson and with dobutamine. The investigators participants will include patients with history of COPD and Asthma, so it will also help us determine feasibility of Regadenoson in these patient's subgroups.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dobutrex

Condition Name

Condition Name for Dobutrex
Intervention Trials
Septic Shock 2
Heart Failure 2
Mitral Valve Stenosis With Incompetence or Regurgitation 1
Subarachnoid Hemorrhage 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dobutrex
Intervention Trials
Heart Failure 3
Shock, Septic 2
Shock 2
Mitral Valve Stenosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dobutrex

Trials by Country

Trials by Country for Dobutrex
Location Trials
Sweden 2
United States 1
Turkey 1
Israel 1
Tunisia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Dobutrex
Location Trials
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dobutrex

Clinical Trial Phase

Clinical Trial Phase for Dobutrex
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
N/A 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dobutrex
Clinical Trial Phase Trials
Completed 5
Unknown status 2
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dobutrex

Sponsor Name

Sponsor Name for Dobutrex
Sponsor Trials
Göteborg University 1
Military Hospital of Tunis 1
Orion Corporation, Orion Pharma 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dobutrex
Sponsor Trials
Other 9
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Colorcon
Merck
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.